PMV Pharmaceuticals, Inc. Stock Analysis & AI Score
PMV Pharmaceuticals, Inc. (PMVP) has an ST Score of 51.4 (C+), driven by its Forecast (A) and held back by its Profitability (D-). Analysts rate it Buy with a $5.00 price target (+274.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
PMV Pharmaceuticals, Inc. (PMVP) has an ST Score of 51.4 (C+), driven by its Forecast (A) and held back by its Profitability (D-). Analysts rate it Buy with a $5.00 price target (+274.5% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityD-
All factor grades
- ForecastA
- Financial StrengthA-
- MomentumB+
- ValuationB-
- GrowthC+
- ProfitabilityD-
- Piotroski1/9
Contact
PMVP stock: frequently asked questions
What is PMVP's ST Score?
PMV Pharmaceuticals, Inc. (PMVP) has an ST Score of 51.4 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PMVP a buy, hold, or sell?
Analysts rate PMVP a Buy, with a price target of $5.00 (+274.5% vs the current price). Our ST Score grades it C+ (51.4/100). The ST Score is a data-driven signal, not a recommendation.
What are PMVP's factor grades?
Valuation B-, Profitability D-, Financial Strength A-, Momentum B+, Growth C+, Forecast A.
What is PMVP's valuation grade?
PMV Pharmaceuticals, Inc. (PMVP) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PMVP's growth grade?
PMV Pharmaceuticals, Inc. (PMVP) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PMVP's profitability grade?
PMV Pharmaceuticals, Inc. (PMVP) earns a profitability grade of D-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PMVP's financial strength grade?
PMV Pharmaceuticals, Inc. (PMVP) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PMVP?
The average analyst price target for PMV Pharmaceuticals, Inc. (PMVP) is $5.00 from 4 analysts, which is +274.5% versus the recent price of $1.33.
What is PMVP's Piotroski score?
PMV Pharmaceuticals, Inc. (PMVP) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.